These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20069086)

  • 1. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
    Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
    Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.
    Bouchard NC; Howland MA; Greller HA; Hoffman RS; Nelson LS
    Mayo Clin Proc; 2005 Apr; 80(4):541-5. PubMed ID: 15819293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence that p-synephrine is responsible for STEMI.
    Stohs SJ
    Tex Heart Inst J; 2010; 37(3):383; author reply 383-4. PubMed ID: 20548833
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium.
    Smith TB; Staub BA; Natarajan GM; Lasorda DM; Poornima IG
    Tex Heart Inst J; 2014 Feb; 41(1):70-2. PubMed ID: 24512406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female.
    Chung H; Kwon SW; Kim TH; Yoon JH; Ma DW; Park YM; Hong BK
    Korean J Intern Med; 2013 May; 28(3):356-60. PubMed ID: 23682231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement.
    Burke J; Seda G; Allen D; Knee TS
    Mil Med; 2007 Jun; 172(6):656-8. PubMed ID: 17615852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation associated with use of synephrine containing dietary supplement.
    Stephensen TA; Sarlay R
    Mil Med; 2009 Dec; 174(12):1313-9. PubMed ID: 20055074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
    Nykamp DL; Fackih MN; Compton AL
    Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
    Holmes RO; Tavee J
    Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Ephedra-free" diet pill-induced psychosis.
    Retamero C; Rivera T; Murphy K
    Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
    [No Abstract]   [Full Text] [Related]  

  • 13. STEMI in a Young Male after Use of Synephrine-Containing Dietary Supplement.
    Unnikrishnan D; Annam R; Jacob A; Thyagarajan B; Farrugia P
    Case Rep Cardiol; 2018; 2018():7074104. PubMed ID: 29808122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine.
    Smedema JP; Müller GJ
    S Afr Med J; 2008 May; 98(5):372-3. PubMed ID: 18637307
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple coronary artery thrombosis in a 41-year-old male patient presenting with ST-segment elevation myocardial infarction.
    Al Suwaidi J; Al-Qahtani A
    J Invasive Cardiol; 2012 Mar; 24(3):E43-6. PubMed ID: 22388313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Case Reports on Adverse Events Related to Pre-workout Supplements Containing Synephrine.
    de Jonge MLL; Kieviet LC; Sierts M; Egberink LB; van der Heyden MAG
    Cardiovasc Toxicol; 2023 Jan; 23(1):1-9. PubMed ID: 36639595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.
    Lemesle G; Sudre A; Bouallal R; Delhaye C; Rosey G; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2010; 11(3):149-54. PubMed ID: 20599164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention.
    Sianos G; Papafaklis MI; Serruys PW
    J Invasive Cardiol; 2010 Oct; 22(10 Suppl B):6B-14B. PubMed ID: 20947930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double coronary artery thrombosis presenting as acute extensive anterior ST-segment elevation myocardial infarction.
    Lee CW; Lai CH; Lu TM
    J Chin Med Assoc; 2013 Jul; 76(7):407-10. PubMed ID: 23664732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.